Logo image of PTHL

PHETON HOLDINGS LTD-A (PTHL) Stock Fundamental Analysis

NASDAQ:PTHL - KYG713991027 - Common Stock

0.6 USD
+0 (+0.2%)
Last: 8/22/2025, 8:00:02 PM
0.6 USD
0 (0%)
After Hours: 8/22/2025, 8:00:02 PM
Fundamental Rating

2

PTHL gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. PTHL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. PTHL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

PTHL had negative earnings in the past year.
PTHL had a negative operating cash flow in the past year.
PTHL Yearly Net Income VS EBIT VS OCF VS FCFPTHL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -200K -400K -600K

1.2 Ratios

Looking at the Return On Assets, with a value of -9.83%, PTHL is in the better half of the industry, outperforming 62.86% of the companies in the same industry.
PTHL has a Return On Equity of -10.68%. This is in the better half of the industry: PTHL outperforms 74.29% of its industry peers.
Industry RankSector Rank
ROA -9.83%
ROE -10.68%
ROIC N/A
ROA(3y)-6.25%
ROA(5y)N/A
ROE(3y)-24.78%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PTHL Yearly ROA, ROE, ROICPTHL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

Looking at the Gross Margin, with a value of 85.05%, PTHL belongs to the top of the industry, outperforming 88.57% of the companies in the same industry.
PTHL's Gross Margin has been stable in the last couple of years.
PTHL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 85.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5YN/A
PTHL Yearly Profit, Operating, Gross MarginsPTHL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

5

2. Health

2.1 Basic Checks

PTHL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PTHL has been increased compared to 1 year ago.
PTHL has a worse debt/assets ratio than last year.
PTHL Yearly Shares OutstandingPTHL Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M
PTHL Yearly Total Debt VS Total AssetsPTHL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

PTHL has an Altman-Z score of 10.20. This indicates that PTHL is financially healthy and has little risk of bankruptcy at the moment.
PTHL's Altman-Z score of 10.20 is amongst the best of the industry. PTHL outperforms 85.71% of its industry peers.
PTHL has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.04, PTHL is in line with its industry, outperforming 57.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 10.2
ROIC/WACCN/A
WACC8.86%
PTHL Yearly LT Debt VS Equity VS FCFPTHL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M 4M 6M

2.3 Liquidity

A Current Ratio of 12.40 indicates that PTHL has no problem at all paying its short term obligations.
PTHL has a Current ratio of 12.40. This is amongst the best in the industry. PTHL outperforms 97.14% of its industry peers.
A Quick Ratio of 12.18 indicates that PTHL has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 12.18, PTHL belongs to the top of the industry, outperforming 97.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 12.4
Quick Ratio 12.18
PTHL Yearly Current Assets VS Current LiabilitesPTHL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for PTHL have decreased strongly by -56.19% in the last year.
PTHL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.79%.
The Revenue for PTHL have been decreasing by -13.92% on average. This is quite bad
EPS 1Y (TTM)-56.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.9%
Revenue 1Y (TTM)-11.79%
Revenue growth 3Y-13.92%
Revenue growth 5YN/A
Sales Q2Q%-1.49%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PTHL Yearly Revenue VS EstimatesPTHL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 200K 400K 600K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PTHL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PTHL Price Earnings VS Forward Price EarningsPTHL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PTHL Per share dataPTHL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PTHL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PHETON HOLDINGS LTD-A

NASDAQ:PTHL (8/22/2025, 8:00:02 PM)

After market: 0.6 0 (0%)

0.6

+0 (+0.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.27%
Inst Owner ChangeN/A
Ins Owners40.29%
Ins Owner ChangeN/A
Market Cap8.55M
AnalystsN/A
Price TargetN/A
Short Float %13.76%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 19.08
P/FCF N/A
P/OCF N/A
P/B 1.38
P/tB 1.38
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.03
BVpS0.43
TBVpS0.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.83%
ROE -10.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 85.05%
FCFM N/A
ROA(3y)-6.25%
ROA(5y)N/A
ROE(3y)-24.78%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5YN/A
F-Score4
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.24%
Cap/Sales 0.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.4
Quick Ratio 12.18
Altman-Z 10.2
F-Score4
WACC8.86%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.79%
Revenue growth 3Y-13.92%
Revenue growth 5YN/A
Sales Q2Q%-1.49%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-66.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1119.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1118.55%
OCF growth 3YN/A
OCF growth 5YN/A